🇺🇸 FDA

Intelligence Platform

Patents

Browse 48 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12070472

Treatment of drug resistant proliferative diseases with telomerase mediated telomere alter

The Board of Regents of the University of Texas System · Granted Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11518750

3-methylideneoxan-4-one compounds and substituted derivatives thereof as inhibitors of tel

Northwestern University · Granted Tue Dec 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11369688

Hybrid telodendrimers

The Regents of the University of California · Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11364202

Solid forms of cannabidiol and uses thereof

Artelo Biosciences, Inc. · Granted Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11219692

Porphyrin modified telodendrimers

The Regents of the University of California · Granted Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10604467

Solid forms of cannabidiol and uses thereof

Artelo Biosciences, Inc. · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10463685

Telomerase mediated telomere altering compounds

The Board of Regents of the University of Texas System · Granted Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10406233

Telodendrimers with enhanced drug delivery

The Regents of the University of California · Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10238750

Porphyrin modified telodendrimers

The Regents of the University of California · Granted Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9642916

Porphyrin modified telodendrimers

The Regents of the University of California · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9012223

Methods for enhancing genome stability and telomere elongation in embryonic stem cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8895055

Telodendrimer nanodiscs without apolipoprotein

The Regents of the University of California · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8796438

Nucleic acids encoding inactive variants of human telomerase

The Regents of the University of Colorado · Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8741649

Methods for enhancing genome stability and telomere elongation in embryonic stem cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8709995

Method for eliciting an immune response to human telomerase reverse transcriptase

The Regents of the University of Colorado · Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8697836

Composition and method for inducing and enhancing a telomerase reverse transcriptase-react

The Regents of the University of California · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8222392

Kit for detection of telomerase reverse transcriptase nucleic acids

The Regents of the University of Colorado · Granted Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7750121

Antibody to telomerase reverse transcriptive

The Regents of the University of Colorado · Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622549

Human telomerase reverse transcriptase polypeptides

The Regents of the University of Colorado · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7585622

Increasing the proliferative capacity of cells using telomerase reverse transcriptase

The Regents of the University of Colorado · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7560437

Nucleic acid compositions for eliciting an immune response against telomerase reverse tran

The Regents of the University of Colorado · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7517971

Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity

The Regents of the University of Colorado · Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7413864

Treating cancer using a telomerase vaccine

The Regents of the University of Colorado · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7388071

Composition and method for inducing and enhancing a telomerase reverse transcriptase-react

The Regents of the University of California · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted